Yourgene Health PLC – Appointment of Director

Yourgene Health PLC – Appointment of Director

Manchester, UK 29 July 2019: Yourgene Health plc (AIM: YGEN), the international molecular diagnostics group which commercialises genetic products and services, announces the appointment of Dr John Brown CBE to the Board of Directors as a Non-executive Director with immediate effect.  Dr Brown will act as the Senior Independent Director on the Board.

Dr Brown has over 20 years’ capital markets experience in the healthcare and life sciences sector. He is currently a Senior Independent Director of BioCity and Acacia Pharma and is Chairman of Cell Therapy Catapult and Synpromics. Additionally, he has previous significant board experience with roles including Chairman of Axis-Shield, Chairman of BTG, Non-executive Director of Vectura and Chief Executive Officer of Acambis.

Further disclosures on Dr Brown as required under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies are included in the appendix below.

Adam Reynolds, Chairman of Yourgene, commented: “We are delighted to welcome John to the Board of Yourgene. John has unrivalled experience in working with publicly listed life sciences businesses and we look forward to drawing on his experience as we drive awareness of Yourgene’s expanded product portfolio across our target markets. John’s skillset and experience is a great strategic fit as Yourgene enters the next phase of its growth journey. We look forward to leveraging the team’s experience and continuing to build a truly international molecular diagnostics business.”

No Comments

Post a Comment